As Trump killed cancer research

But then Trump decided that American Science Research was, in some way, too awakened. He paused the concession of Nih subsidies for more than two months, supporting an estimated financing of $ 1.5 billion. He actually interrupted the clinical studies of new drugs. He fired thousands of employees of the FDA, NiH and the centers for the control and prevention of diseases. At the Department of Veterans’ affairs, about 35 million dollars in research already financed, including cancer, was thrown in danger when Trump established a freezing of hires. At the APA, the staff were asked to cancel the existing grants, also at the Health Effects Institute, who published research on the link between air pollution and cancer. And to the extent of financing by Stopgap, which will expire in September, the Republicans have cut about 60 % from the medical research programs directed by the Congress of the Department of Defense, including funding for searching on breast and ovar cancers. (Pancreas, kidneys and lung cancer programs disappeared from the list of the agency’s financed projects and launched another program, which did not receive additional funding for 2025.) at the National Institutes of Health, some grants have taken up and others have been foreseen for the resolution. The current state of the United States cancer research could be described fairly as – confusion.

While researchers from all over the country have lost subsidies, two of the political objectives of the Trump administration – Columbia and Harvard – were affected particularly hard. And throughout the line, many of these subsidies of subsidies seem to be part of the anti-dei, anti-trans-trans and anti-vacaccini agendas of the Administration. According to reports, Trump’s officials maintain a list of “marked” keywords who believe should trigger the program reviews. In the Nih subsidies finished so far, the 50 most common marked words include trans, expression, different and women.